Black Titan Corp (NASDAQ:BTTC) Short Interest Update

Black Titan Corp (NASDAQ:BTTC) was the target of a significant decline in short interest in September. As of September 15th, there was short interest totaling 10,495 shares, a decline of 51.6% from the August 31st total of 21,671 shares. Approximately 0.2% of the company’s stock are sold short. Based on an average daily volume of 108,286 shares, the days-to-cover ratio is currently 0.1 days.

Black Titan Stock Up 1.7%

NASDAQ:BTTC traded up $0.01 on Tuesday, hitting $0.44. 319,703 shares of the company’s stock were exchanged, compared to its average volume of 3,491,045. Black Titan has a 52 week low of $0.34 and a 52 week high of $39.00. The company has a market cap of $4.75 million, a P/E ratio of -0.15 and a beta of 1.17. The company has a debt-to-equity ratio of 0.06, a current ratio of 4.62 and a quick ratio of 4.62. The firm has a 50-day moving average price of $0.59 and a 200-day moving average price of $0.94.

About Black Titan

Titan Pharmaceuticals, Inc is a biopharmaceutical company developingproprietary therapeutics for the treatment of central nervous system disorders, cancer, and other serious and life threatening diseases. In the central nervous system arena, the company is developing iloperidone, which is clinical testing for schizophrenia through a licensing and development agreement with Novartis Pharma AG. Novartis has tradenamed the product Zomaril.